Publication date: Feb 17, 2025

Chronic obstructive pulmonary disease (COPD) is a risk factor for severe COVID-19. However, mortality after COVID-19 recovery in this population remains unclear. We retrospectively enrolled individuals with COPD from the Korean National Health Insurance database. We compared the mortality rate in individuals with COPD who recovered from COVID-19 between 8 October 2020 and 31 December 2021 (COVID-19 cohort, n=2499) with that in 1:1 propensity score-matched controls (n=2499). The study population was followed until either death or 30 September 2022, whichever came first. The COVID-19 cohort had a 4. 8% mortality rate vs 2. 7% in matched controls during a median follow-up of 319 days (IQR, 293-422 days), including 14 days of recovery time. The COVID-19 cohort had a higher risk of death than matched controls (adjusted HR (aHR)=1. 81, 95% CI=1. 35 to 2. 45). The risk of mortality was notably higher in individuals with severe COVID-19 (aHR=5. 05, 95% CI=3. 65 to 6. 97), especially during the first 180 days of recovery (highest during the first 30 days (aHR=20. 25, 95% CI=7. 79 to 52. 64)). Non-severe COVID-19 does not increase the risk of mortality compared with controls (aHR=0. 85, 95% CI=0. 57 to 1. 28). Individuals with COPD recovering from COVID-19 showed an increased risk of long-term mortality, particularly within the first 180 days post-recovery, especially those who experienced severe COVID-19.

Open Access PDF

Semantics

Original Article